Cytokinetics | CYTK - Market Capitalization



Cytokinetics reported $5.87B in Market Capitalization this September of 2025, considering the latest stock price and the number of outstanding shares.


Market Capitalization Change Date
Acadia Pharmaceuticals USD 3.61B 840M Jun/2025
Amgen USD 150.13B 17.37B Jun/2025
Bayer EUR 25.09B 3.38B Jun/2025
Biogen USD 18.41B 1.62B Jun/2025
Bristol-Myers Squibb USD 94.2B 29.9B Jun/2025
Cytokinetics USD 3.95B 846M Jun/2025
Eli Lilly USD 738.79B 2.87B Jun/2025
Geron USD 898M 115M Jun/2025
Halozyme Therapeutics USD 6.41B 1.47B Jun/2025
Ionis Pharmaceuticals USD 6.29B 1.49B Jun/2025
Ligand Pharmaceuticals USD 2.19B 168M Jun/2025
Merck USD 198.77B 27.1B Jun/2025
Novartis CHF 256.18B 64.49B Jun/2025
Pfizer USD 137.53B 6.19B Jun/2025
Regeneron Pharmaceuticals USD 55.87B 13.47B Jun/2025
Sanofi EUR 100.06B 25.78B Jun/2025